Environmental Assessment
Publications
Ordered by:
Below is a list of ORD publications that meet you research criteria. To view a complete abstract and other detailed information, simply select the title which will allow you to drill-down to more information. Your search has returned 18 matching records
U.S. EPA. Approaches For the Application of Physiologically Based Pharmacokinetic (PBPK) Models and Supporting Data In Risk Assessment (Final Report). U.S. Environmental Protection Agency, Washington, D.C., EPA/600/R-05/043F, 2006.
U.S. EPA. Benchmark Dose Software Development And Maintenance Ten Berge Cxt Models. U.S. Environmental Protection Agency, Washington, DC, EPA/600/C-08/009, 2008.
NADADUR, S. S. AND D. L. COSTA. Challenges Facing Low Dose Inhalation Toxicology Studies: Metrics, Models, Extrapolations, Biomarkers And Countless. Presented at Society of Toxicology Annual Meeting, Seattle, WA, March 16 - 20, 2008.
Eastmond, D. A. Chemical And Radiation Leukemogenesis In Humans And Rodents And The Value Of Rodent Models For Assessing Risks Of Lymphohematopoietic Cancers. U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, Washington Office, Washington, DC, EPA/600/R-97/090, 1997.
Gift, J., J. Caldwell, AND R. Setzer. A Consumer's Guide To Benchmark Dose Models (BMDS): Results Of U.S. EPA Testing Of 14 Dichotomous, 8 Continuous, And 6 Developmental Models (Presentation). Presented at Annual SRA Meeting, December 1999.
CALDWELL, J. C., M. V. EVANS, AND K. Krishnan. Cutting Edge PBPK Models And Analyses: Providing The Basis For Future Modeling Efforts And Bridges To Emerging Toxicology Paradigms [Journal Article]. , Journal of Toxicology. Hindawi Publishing Corporation, New York, NY, 2012:10, (2012).
U.S. EPA. Development and Evaluation of Novel Dose-Response Models For Use In Microbial Risk Assessment. U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-08/033, 2008.
Lorber, M. AND P. Pinsky. An Evaluation Of Three Empirical Air-To-Leaf Models For Polychlorinated Dibenzo-P-Dioxins And Dibenzofurans. , CHEMOSPHERE. Elsevier Science Ltd, New York, NY, 41(6):931-941, (2000).
Marcus, A. Multivariate Statistical Models For Effects Of PM And Copollutants In A Daily Time Series Epidemiology Study. Presented at Third Colloquium on Particulate Air Pollution and Human Health, June 6-8, 1999.
U.S. EPA. Peer Review of EPA's Draft BMDS Document: Exponential Continuous Models (External Review Draft, Version 1.1). 2007.
Norton, S B., S Cormier, M. Smith, R. C. Jones, AND M. SchubauerBerigan. Predicting Levels Of Stress From Biological Assessment Data: Empirical Models From The Eastern Corn Belt Plains. ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY 21(6):1168-1175, (2002).
CHIU, W. AND P. WHITE. Steady-State Solutions To PBPK Models And Their Applications To Risk Assessment I: Route-To-Route Extrapolation Of Volatile Chemicals - Authors' Response To Letter By Dr. Kenneth Bogen. , RISK ANALYSIS. Blackwell Publishing, Malden, MA, 26(3):769-780, (2006).
CHIU, W. Uncertainties In Trichloroethylene Pharmacokinetic Models. , INSIDE EPA. Inside Washington Publishers, Washington, DC, 13(20), (2006).
U.S. EPA. Uncertainty And Variability In Physiologically-Based Pharmacokinetic (PBPK) Models: Key Issues And Case Studies (Final Report). U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-08/090.
U.S. EPA. Updates To The Demographic And Spatial Allocation Models To Produce Integrated Climate And Land Use Scenarios (Iclus) (Final Report, Version 2). U.S. Environmental Protection Agency, Washington, DC, EPA/600/R-16/366F, 2017.
U.S. EPA. Use Of Physiologically Based Pharmacokinetic (PBPK) Models To Quantify The Impact Of Human Age And Interindividual Differences In Physiology And Biochemistry Pertinent To Risk (Final Report). U.S. Environmental Protection Agency, Washington, D.C., EPA/600/R-06/014A.